Results 131 to 140 of about 62,879 (264)

Differential effects of central blood volume loading and unloading on pulmonary diffusing capacity in humans

The Journal of Physiology, EarlyView.
Abstract figure legend Central blood volume (CBV) is a key haemodynamic determinant of pulmonary diffusing capacity for carbon monoxide (DLCO) and its components, capillary blood volume (Vc) and membrane diffusing capacity (Dm,CO). However the contribution of CBV to DLCO regulation remains poorly defined. We investigated the effects of graded increases
Andrew W. D'Souza, Andrew R. Brotto, Thomas G. Williams, Chuanyi Foo, Eli Bok, Desi P. Fuhr, Jason Weatherald, Sean van Diepen, Michael K. Stickland   +8 more
wiley   +1 more source

Redo surgical aortic valve replacement versus valve-in-valve transcatheter aortic valve replacement with balloon valve fracture: Short-term clinical outcomes. [PDF]

JTCVS Struct Endovasc
Kanade R, Tagliafierro M, Anzai I, Soliman F, Mitchell WM, Kirilina D, Kurlansky P, Hahn RT, Kodali S, Nazif TM, Vahl TP, Geirsson A, Argenziano M, George I, Pirelli L.   +14 more
europepmc   +1 more source

Puerarin‐Loaded Macrophage‐Derived Exosomes for Experimental Atherosclerosis

Food Frontiers, Volume 7, Issue 5, September 2026.
We developed a macrophage‐derived exosome‐based delivery system to enhance the therapeutic efficacy of puerarin (Pue) against atherosclerosis (AS). Exosomes were isolated from RAW264.7 cells, co‐cultured with Pue, and comprehensively characterized for morphology, stability, and drug loading.
Zijian Zou, Liangxing Tu, Ye Yang, Jianfang Feng, Yi Jin, Ruyue Yang, Meng Cheng   +6 more
wiley   +1 more source

Early Outcomes of Real-World Aortic Valve Replacement With RESILIA Tissue in the Chinese Population. [PDF]

Clin Cardiol
Xu H, Yan Y, Chen X, Wang J, Sun H.
europepmc   +1 more source

miR‐138‐5p Inhibits Aortic Valve Interstitial by Targeting SLC39A14 and Activating Nrf2 Signaling

Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 9, September 2026.
Nrf2 Pathway Inhibition Attenuates miR‐138‐5p's Anti‐Calcification Effects in OM‐Induced hAVICs. A. ALP staining for ALP activity assessment in NC‐mimic, miR‐mimic, and miR‐mimic + ML385 groups. B. Alizarin Red staining for osteogenesis and calcium nIn osteogenic medium‐induced human aortic valve interstitial cells (hAVICs), miR‐138‐5p targets SLC39A14
Fei Yan, Ying Zhao, Yuanyuan Wu, Dubiao Xian, Lei Shi, Yunheng Liang, Ning Wang, Ruiling He, Hongwang Cui, Zhihao Xie   +9 more
wiley   +1 more source

New Horizons in Transcatheter Aortic Valve Replacement: Expectations and Preparations. [PDF]

J Clin Med
Nawaz H, Dahou A, Ahmad T.
europepmc   +1 more source

Cost‐effectiveness of in‐hospital motivational smoking cessation counselling and proactive referral to community‐based follow‐up

Addiction, Volume 121, Issue 9, Page 2384-2395, September 2026.
Abstract Background and aim In a randomised open‐label trial among hospitalised patients with atherosclerotic vascular disease, motivational smoking cessation counselling with proactive referral to community‐based follow‐up was more effective than brief cessation advice and written information, with 6‐month continuous abstinence rates of 49.5% vs. 24.5%
Karin Pleym, Ingrid Engebretsen, Elise Sverre, Toril Dammen, Einar Huseby, Mohpal Singh Kahlon, Marie Stugaard, Henrik Støvring, Ivar Sønbø Kristiansen, John Munkhaugen   +9 more
wiley   +1 more source

What Will Define the Next Era of Transcatheter Aortic Valve Replacement: Cost, Volume, and Quality? [PDF]

JACC Asia
Iwata J, Hayashida K.
europepmc   +1 more source

HOMOGRAFT REPLACEMENT OF THE AORTIC VALVE

The Lancet, 1968
A McDonald, L McDonald, L Resenkov, M Robinson, D Ross   +4 more
openaire   +2 more sources

Anti‐inflammatory agents in atherosclerosis—and a need for reform: Extraordinary claims require extraordinary evidence

Journal of Internal Medicine, Volume 300, Issue 3, Page 258-283, September 2026.
Abstract Since 1858, human atherosclerotic plaques have been shown to contain immune cells. But are these cells suitable therapeutic targets? Dozens of clinical trials of anti‐inflammatory agents other than colchicine have been performed in patients with clinically evident atherosclerosis.
Kevin Jon Williams
wiley   +1 more source